Medicine shortages in France
Live register of drug shortage notices in France, aggregated daily from official regulator publications and linked back to every source.
Latest shortage notices in France
| Medicine | Status | Severity | Since | Source |
|---|---|---|---|---|
| Ornidazole | active | high | 31 Jul 2026 | ANSM |
| Amikacine (Sulfate D') | anticipated | medium | 31 Jul 2026 | ANSM |
| Virus Della Parotite Ceppo Jeryl Lynn (Livello B) (Vivo, Attenuato) Prodotto Su Cellule Embrionali Di Pollo + Virus Della Rosolia Ceppo Wistar Ra 27/3 (Vivo,Attenuato) + Virus Della Varicella Vivo Attenuato(Ceppo Oka) + Virus Vivo Attenuato Del Morbillo (Ceppo Schwarz) | anticipated | medium | 31 Jul 2026 | ANSM |
Official sources for France
- France BDPM (Base de données publique des médicaments) (BDPM) — official register · last checked 22 Jun 2026
- Agence nationale de sécurité du médicament — Disponibilité (ANSM) — official register · last checked 2 Aug 2026
Frequently asked questions
How many medicines are in shortage in France?
France currently has 121 active medicine shortage notices and 327 anticipated. Figures update daily from official regulator publications.
Who reports medicine shortages in France?
Official shortage notices for France are published by France BDPM (Base de données publique des médicaments) (BDPM), Agence nationale de sécurité du médicament — Disponibilité (ANSM). Mederti checks these sources daily and links every notice back to the original publication.
How current is this France shortage data?
Mederti scrapes France's official shortage register daily. Each notice carries the regulator's own dates; the list on this page reflects the most recent successful update.
Track France shortages that matter to you
Watchlists, email alerts, alternatives and cross-country comparison — free for individual pharmacists and clinicians.
Create a free accountData is aggregated from official sources and provided for information only. Mederti is not affiliated with or endorsed by any regulator. Verify with BDPM before clinical or procurement decisions.